The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen.
The major bullous pemphigoid (BP) antigen is a 220-240-kDa polypeptide, although some BP sera recognize bands of 180-200 kDa or lower molecular weight. We have investigated to what extent this heterogeneity of the target antigen accounts for the clinical diversity of BP. Immunoblotting studies again...
| Автори: | , , , , |
|---|---|
| Формат: | Journal article |
| Мова: | English |
| Опубліковано: |
1991
|
| _version_ | 1826291486600200192 |
|---|---|
| author | Venning, V Whitehead, P Leigh, I Allen, J Wojnarowska, F |
| author_facet | Venning, V Whitehead, P Leigh, I Allen, J Wojnarowska, F |
| author_sort | Venning, V |
| collection | OXFORD |
| description | The major bullous pemphigoid (BP) antigen is a 220-240-kDa polypeptide, although some BP sera recognize bands of 180-200 kDa or lower molecular weight. We have investigated to what extent this heterogeneity of the target antigen accounts for the clinical diversity of BP. Immunoblotting studies against extracts of salt-separated epidermis were performed on sera from 39 patients with BP. The blotting patters obtained were correlated with the clinical findings, with particular reference to prodromal itching, lesion morphology and severity, mucosal involvement, presence of milia, dapsone responsiveness and disease duration. The results confirm that the major BP antigen is a 220-kDa polypeptide, and that the 180-kDa polypeptide is a second and sometimes the sole BP antigen identified in immunoblots. Rarely, multiple bands of lower molecular weight were found. There was no correlation between the pattern of BP antigens detected in immunoblots and the clinical presentation and course of BP. There was considerable clinical diversity even among the nine patients showing specificity for a single 220-kDa target antigen. Although two patients with a single 180-kDa antigen specificity had a disease of unusually long duration, factors other than antigen specificity must determine the clinical expression of BP. |
| first_indexed | 2024-03-07T03:00:07Z |
| format | Journal article |
| id | oxford-uuid:b0aefa61-6889-4eec-a5fa-f1a7eb777284 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:00:07Z |
| publishDate | 1991 |
| record_format | dspace |
| spelling | oxford-uuid:b0aefa61-6889-4eec-a5fa-f1a7eb7772842022-03-27T03:58:12ZThe clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b0aefa61-6889-4eec-a5fa-f1a7eb777284EnglishSymplectic Elements at Oxford1991Venning, VWhitehead, PLeigh, IAllen, JWojnarowska, FThe major bullous pemphigoid (BP) antigen is a 220-240-kDa polypeptide, although some BP sera recognize bands of 180-200 kDa or lower molecular weight. We have investigated to what extent this heterogeneity of the target antigen accounts for the clinical diversity of BP. Immunoblotting studies against extracts of salt-separated epidermis were performed on sera from 39 patients with BP. The blotting patters obtained were correlated with the clinical findings, with particular reference to prodromal itching, lesion morphology and severity, mucosal involvement, presence of milia, dapsone responsiveness and disease duration. The results confirm that the major BP antigen is a 220-kDa polypeptide, and that the 180-kDa polypeptide is a second and sometimes the sole BP antigen identified in immunoblots. Rarely, multiple bands of lower molecular weight were found. There was no correlation between the pattern of BP antigens detected in immunoblots and the clinical presentation and course of BP. There was considerable clinical diversity even among the nine patients showing specificity for a single 220-kDa target antigen. Although two patients with a single 180-kDa antigen specificity had a disease of unusually long duration, factors other than antigen specificity must determine the clinical expression of BP. |
| spellingShingle | Venning, V Whitehead, P Leigh, I Allen, J Wojnarowska, F The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title | The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title_full | The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title_fullStr | The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title_full_unstemmed | The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title_short | The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. |
| title_sort | clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen |
| work_keys_str_mv | AT venningv theclinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT whiteheadp theclinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT leighi theclinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT allenj theclinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT wojnarowskaf theclinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT venningv clinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT whiteheadp clinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT leighi clinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT allenj clinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen AT wojnarowskaf clinicalexpressionofbullouspemphigoidisnotdeterminedbythespecificityofthetargetantigen |